INTERPACE BIOSCIENCES, INC. (IDXG) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
WATERVIEW PLAZA, SUITE 310 PARSIPPANY, NJ 07054 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3,498 | 4,828 | 3,064 | 2,772 | 2,321 | 6,068 | |||
| Cash and cash equivalent | 3,498 | 4,828 | 3,064 | 2,772 | 2,321 | 6,068 | |||
| Restricted cash and investments | 250 | ||||||||
| Receivables | 4,983 | 5,032 | 6,158 | 8,028 | 10,197 | 9,483 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,227 | 1,224 | 1,786 | 2,052 | 1,825 | ||||
| Inventory | 1,227 | 1,224 | 1,786 | 2,052 | 1,825 | ||||
| Other current assets | 1,841 | 2,294 | 2,694 | 2,722 | 3,851 | 2,170 | |||
| Other undisclosed current assets | (1,227) | (1,224) | (1,786) | (1,452) | (1,825) | ||||
| Total current assets: | 10,322 | 12,154 | 12,166 | 14,122 | 16,369 | 17,721 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,864 | 2,439 | 4,032 | 4,384 | ✕ | ||||
| Property, plant and equipment | 790 | 480 | 6,349 | 7,349 | 6,814 | 837 | |||
| Intangible assets, net (including goodwill) | 861 | 15,720 | 19,784 | 41,934 | 29,853 | ||||
| Goodwill | 8,433 | 8,433 | 8,433 | ||||||
| Intangible assets, net (excluding goodwill) | 861 | 7,287 | 11,351 | 33,501 | 29,853 | ||||
| Other noncurrent assets | 45 | 45 | 160 | 42 | 42 | 31 | |||
| Other undisclosed noncurrent assets | 3,892 | ||||||||
| Total noncurrent assets: | 2,699 | 3,825 | 26,261 | 31,559 | 52,682 | 30,721 | |||
| TOTAL ASSETS: | 13,021 | 15,979 | 38,427 | 45,681 | 69,051 | 48,442 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 11,714 | 10,925 | 14,916 | 17,467 | 7,753 | 7,574 | |||
| Taxes payable | ✕ | ✕ | ✕ | 403 | |||||
| Employee-related liabilities | ✕ | ✕ | ✕ | 3,024 | 3,161 | 2,341 | 1,424 | ||
| Accounts payable | 1,544 | 1,050 | 2,694 | 4,511 | 4,812 | 1,059 | |||
| Accrued liabilities | 10,170 | 9,875 | 9,198 | 9,795 | 197 | 5,091 | |||
| Deferred revenue | 457 | ✕ | |||||||
| Debt | 5,100 | 578 | 1,505 | ||||||
| Disposal group, including discontinued operation | 660 | 858 | 766 | 766 | 766 | 918 | |||
| Business combination, contingent consideration, liability | 502 | ||||||||
| Due to related parties | ✕ | ✕ | 888 | ||||||
| Other undisclosed current liabilities | 1,922 | 5,427 | |||||||
| Total current liabilities: | 17,474 | 14,283 | 15,682 | 18,233 | 17,298 | 8,492 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 4,243 | 1,848 | 3,213 | 3,678 | 2,714 | ||||
| Long-term debt, excluding current maturities | 4,243 | 11,165 | 7,942 | ||||||
| Finance lease, liability | 138 | 123 | ✕ | ||||||
| Other undisclosed long-term debt and lease obligation | (9,317) | (7,883) | |||||||
| Liabilities, other than long-term debt | 6,440 | 7,067 | 6,031 | 6,455 | 6,964 | 3,958 | |||
| Liability for uncertainty in income taxes | 3,838 | ||||||||
| Other liabilities | 4,968 | 4,701 | 4,648 | 4,637 | 4,573 | 120 | |||
| Operating lease, liability | 1,472 | 1,848 | 3,154 | 3,540 | 2,591 | ✕ | |||
| Business combination, contingent consideration, liability | 518 | 1,383 | 1,818 | 2,391 | |||||
| Other undisclosed noncurrent liabilities | 9,317 | 9,383 | (138) | (5,105) | 361 | ||||
| Total noncurrent liabilities: | 10,683 | 18,232 | 18,627 | 9,995 | 4,573 | 4,319 | |||
| Other undisclosed liabilities | 7,982 | 2,693 | |||||||
| Total liabilities: | 28,157 | 32,515 | 34,309 | 28,228 | 29,853 | 15,504 | |||
| Temporary equity, including noncontrolling interest | 46,536 | 46,536 | 46,536 | 26,172 | |||||
| Equity | |||||||||
| Equity, attributable to parent | (61,672) | (63,072) | (42,418) | (29,083) | 13,026 | 32,938 | |||
| Common stock | 405 | 405 | 403 | 402 | 393 | 287 | |||
| Treasury stock, value | (2,008) | (1,976) | (1,868) | (1,773) | (1,721) | (1,680) | |||
| Additional paid in capital | 188,146 | 187,516 | 186,106 | 184,404 | 182,514 | 175,820 | |||
| Accumulated deficit | (248,215) | (249,017) | (227,059) | (212,116) | (168,160) | (141,489) | |||
| Other undisclosed equity | 46,536 | ||||||||
| Total equity: | (61,672) | (63,072) | (42,418) | 17,453 | 13,026 | 32,938 | |||
| TOTAL LIABILITIES AND EQUITY: | 13,021 | 15,979 | 38,427 | 45,681 | 69,051 | 48,442 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 40,214 | 5,678 | 41,314 | 32,398 | 24,079 | 21,896 | ||
| Cost of revenue | (16,310) | (13,607) | (23,369) | (21,673) | (15,888) | (10,197) | ||
| Cost of product and service sold | (10,197) | |||||||
| Other undisclosed gross profit | 26,160 | |||||||
| Gross profit: | 23,904 | 18,231 | 17,945 | 10,725 | 8,191 | 11,699 | ||
| Operating expenses | (21,100) | (21,848) | (31,942) | (36,791) | (34,614) | (23,818) | ||
| Operating income (loss): | 2,804 | (3,617) | (13,997) | (26,066) | (26,423) | (12,119) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (667) | (1,211) | (496) | 467 | 196 | 263 | ||
| Interest and debt expense | (896) | (920) | (549) | (440) | (331) | |||
| Income (loss) from continuing operations before equity method investments, income taxes: | 1,241 | (4,828) | (15,413) | (26,148) | (26,667) | (12,187) | ||
| Other undisclosed loss from continuing operations before income taxes | (112) | (1,008) | ||||||
| Income (loss) from continuing operations before income taxes: | 1,129 | (5,836) | (15,413) | (26,148) | (26,667) | (12,187) | ||
| Income tax expense (benefit) | (17) | (29) | 667 | (53) | 28 | (18) | ||
| Income (loss) from continuing operations: | 1,112 | (5,865) | (14,746) | (26,201) | (26,639) | (12,205) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (14,943) | (26,451) | (26,727) | (12,189) | |
| Income (loss) from discontinued operations | (310) | (16,093) | (197) | (250) | (88) | 16 | ||
| Net income (loss) attributable to parent: | 802 | (21,958) | (14,943) | (26,451) | (26,727) | (12,189) | ||
| Preferred stock dividends and other adjustments | (3,033) | (429) | ||||||
| Net income (loss) available to common stockholders, diluted: | 802 | (21,958) | (14,943) | (29,484) | (27,156) | (12,189) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 802 | (21,958) | (14,943) | (26,451) | (26,727) | (12,189) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 802 | (21,958) | (14,943) | (26,451) | (26,727) | (12,189) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.